| Recent advances on thermosensitive and pH-sensitive liposomes employed in controlled release MA Aghdam, R Bagheri, J Mosafer, B Baradaran, M Hashemzaei, ... Journal of Controlled Release 315, 1-22, 2019 | 160 | 2019 |
| PD‐1/PD‐L1‐dependent immune response in colorectal cancer Z Payandeh, S Khalili, MH Somi, M Mard‐Soltani, A Baghbanzadeh, ... Journal of cellular physiology 235 (7-8), 5461-5475, 2020 | 102 | 2020 |
| The roles of signaling pathways in SARS-CoV-2 infection; lessons learned from SARS-CoV and MERS-CoV N Hemmat, Z Asadzadeh, NK Ahangar, H Alemohammad, B Najafzadeh, ... Archives of Virology 166, 675-696, 2021 | 81 | 2021 |
| Immune checkpoints and CAR-T cells: the pioneers in future cancer therapies? N Hosseinkhani, A Derakhshani, O Kooshkaki, M Abdoli Shadbad, ... International Journal of Molecular Sciences 21 (21), 8305, 2020 | 77 | 2020 |
| Prognostic role and clinical significance of tumor-infiltrating lymphocyte (TIL) and programmed death ligand 1 (PD-L1) expression in triple-negative breast cancer (TNBC): a … P Lotfinejad, M Asghari Jafarabadi, M Abdoli Shadbad, T Kazemi, ... Diagnostics 10 (9), 704, 2020 | 77 | 2020 |
| Interactions between cancer stem cells, immune system and some environmental components: friends or foes? F Vahidian, PHG Duijf, E Safarzadeh, A Derakhshani, A Baghbanzadeh, ... Immunology letters 208, 19-29, 2019 | 68 | 2019 |
| Targeting ROCK signaling in health, malignant and non-malignant diseases R Shahbazi, B Baradaran, M Khordadmehr, S Safaei, A Baghbanzadeh, ... Immunology letters 219, 15-26, 2020 | 66 | 2020 |
| The potential role of miR‐29 in health and cancer diagnosis, prognosis, and therapy M Alizadeh, A Safarzadeh, F Beyranvand, F Ahmadpour, ... Journal of cellular physiology 234 (11), 19280-19297, 2019 | 65 | 2019 |
| Pancreatic cancer signaling pathways, genetic alterations, and tumor microenvironment: The barriers affecting the method of treatment D Javadrashid, A Baghbanzadeh, A Derakhshani, P Leone, N Silvestris, ... Biomedicines 9 (4), 373, 2021 | 62 | 2021 |
| Promising approaches in cancer immunotherapy N Taefehshokr, B Baradaran, A Baghbanzadeh, S Taefehshokr Immunobiology 225 (2), 151875, 2020 | 62 | 2020 |
| Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer S Najjary, R Mohammadzadeh, A Mokhtarzadeh, A Mohammadi, ... Gene 738, 144453, 2020 | 57 | 2020 |
| Tumor-associated macrophages: Protumoral macrophages in inflammatory tumor microenvironment S Malekghasemi, J Majidi, A Baghbanzadeh, J Abdolalizadeh, ... Advanced Pharmaceutical Bulletin 10 (4), 556, 2020 | 54 | 2020 |
| Immune checkpoint inhibitors in colorectal cancer: challenges and future prospects S Makaremi, Z Asadzadeh, N Hemmat, A Baghbanzadeh, A Sgambato, ... Biomedicines 9 (9), 1075, 2021 | 51 | 2021 |
| The oncogenic potential of NANOG: An important cancer induction mediator B Najafzadeh, Z Asadzadeh, R Motafakker Azad, A Mokhtarzadeh, ... Journal of cellular physiology 236 (4), 2443-2458, 2021 | 49 | 2021 |
| Potential in vivo delivery routes of postbiotics A Abbasi, N Hajipour, P Hasannezhad, A Baghbanzadeh, ... Critical Reviews in Food Science and Nutrition 62 (12), 3345-3369, 2022 | 47 | 2022 |
| The importance of immune checkpoints in immune monitoring: A future paradigm shift in the treatment of cancer H Alemohammad, B Najafzadeh, Z Asadzadeh, A Baghbanzadeh, ... Biomedicine & Pharmacotherapy 146, 112516, 2022 | 46 | 2022 |
| The positive and negative immunoregulatory role of B7 family: promising novel targets in gastric cancer treatment N Bolandi, A Derakhshani, N Hemmat, A Baghbanzadeh, Z Asadzadeh, ... International Journal of Molecular Sciences 22 (19), 10719, 2021 | 45 | 2021 |
| MiR-144: a new possible therapeutic target and diagnostic/prognostic tool in cancers O Kooshkaki, Z Rezaei, M Rahmati, P Vahedi, A Derakhshani, O Brunetti, ... International journal of molecular sciences 21 (7), 2578, 2020 | 45 | 2020 |
| Regulatory mechanisms of microRNAs in colorectal cancer and colorectal cancer stem cells M Shirmohamadi, E Eghbali, S Najjary, A Mokhtarzadeh, AB Kojabad, ... Journal of cellular physiology 235 (2), 776-789, 2020 | 45 | 2020 |
| Nanog, as a key cancer stem cell marker in tumor progression P Vasefifar, R Motafakkerazad, LA Maleki, S Najafi, F Ghrobaninezhad, ... Gene 827, 146448, 2022 | 41 | 2022 |
